Читать книгу Assisted Reproduction Techniques - Группа авторов - Страница 139

There is considerable worldwide experience with the use of bromocriptine to induce pregnancy and during pregnancy. The incidence of miscarriage, ectopic pregnancies or congenital malformations is no higher in mothers who conceived while taking bromocriptine than in the general population [1,28,29]. Cabergoline has also demonstrated a good safety record, although the number of pregnancies studied is smaller [1,22]. Despite this, it is recommended that dopamine agonists be stopped once the first menstrual period has been missed and a positive pregnancy test is obtained [1].